| 1.35 -0.1 (-6.9%) | 01-30 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.92 | 1-year : | 2.25 |
| Resists | First : | 1.64 | Second : | 1.92 |
| Pivot price | 1.58 |
|||
| Supports | First : | 1.18 | Second : | 0.98 |
| MAs | MA(5) : | 1.44  |
MA(20) : | 1.6 |
| MA(100) : | 1.73 |
MA(250) : | 2.43 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 22.5 |
D(3) : | 27.5 |
| RSI | RSI(14): 41.5 |
|||
| 52-week | High : | 7.12 | Low : | 1.01 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ ALUR ] has closed above bottom band by 17.6%. Bollinger Bands are 56.2% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 16 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 1.46 - 1.47 | 1.47 - 1.47 |
| Low: | 1.33 - 1.34 | 1.34 - 1.35 |
| Close: | 1.34 - 1.35 | 1.35 - 1.36 |
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company is headquartered in Natick, Massachusetts.
Mon, 12 Jan 2026
Allurion Announces Preliminary Fourth Quarter and Full-Year 2025 Results - Business Wire
Fri, 19 Dec 2025
Allurion Shareholders Approve Governance Changes and Capital Actions - TipRanks
Tue, 25 Nov 2025
Allurion (NYSE: ALUR) Posts 23% Weight Loss, 14% Lean Mass Gain With Low-Dose Tirzepatide - Stock Titan
Wed, 12 Nov 2025
Earnings call transcript: Allurion Technologies sees Q3 revenue drop amid market shifts - Investing.com
Tue, 11 Nov 2025
Economic Insights on ALUR: What to Know About Recent Market Movement - timothysykes.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 12 (M) |
| Shares Float | 5 (M) |
| Held by Insiders | 8.4 (%) |
| Held by Institutions | 70.4 (%) |
| Shares Short | 444 (K) |
| Shares Short P.Month | 549 (K) |
| EPS | -16.21 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -10.69 |
| Profit Margin | -298 % |
| Operating Margin | -362.3 % |
| Return on Assets (ttm) | -65.4 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | -50.5 % |
| Gross Profit (p.s.) | 0.85 |
| Sales Per Share | 1.4 |
| EBITDA (p.s.) | -2.85 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -37 (M) |
| Levered Free Cash Flow | -17 (M) |
| PE Ratio | -0.09 |
| PEG Ratio | 0 |
| Price to Book value | -0.13 |
| Price to Sales | 0.96 |
| Price to Cash Flow | -0.45 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|